Theravance Biopharma, Inc. (TBPH) NASDAQ

18.73

+0.16(+0.86%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap459.65M
Enterprise Value471.67M
P/E Ratio57.92
PEG Ratio0.44
Price/Sales Ratio11.82
Price/Book Ratio4.07
Enterprise/Revenue10.19
Enterprise/EBITDA15.62

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.2
Operating Margin-0.41

Management Effectiveness

Return On Assets0.04
Return On Equity0.08

Income Statement

Revenue64.38M
Revenue/Share1.59
Gross Profit64.38M
EBITDA-38.45M
Net Income-56.42M
Diluted EPS-1.15

Balance Sheet

Total Cash329.68M
Total Cash/Share6.53
Total Debt44.6M
Total Debt/Equity0.19
Current Ratio9.48
Book Value Per Share4.61

Price History

52-Week Change90.15
52-Week High20.33
52-Week Low7.9
Moving Average 50 Days16.78
Moving Average 200 Days12.59

Statistics

Average Volume461,561
Shares Outstanding50.67M
% Held by Institutions96.43

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A